The post Robert Kiyosaki Says Bitcoin ETFs for “Losers,” Applauds Trump’s Crypto Order appeared first on Coinpedia Fintech News Robert Kiyosaki has brought back his fight against exchange-traded funds, dismissing them as investments for “losers” even as Bitcoin ETFs recorded $552 million in inflows this week.  At the same time, the Rich Dad Poor Dad author threw his support behind President Donald Trump’s new executive order, which opens U.S. retirement accounts to crypto and …The post Robert Kiyosaki Says Bitcoin ETFs for “Losers,” Applauds Trump’s Crypto Order appeared first on Coinpedia Fintech News Robert Kiyosaki has brought back his fight against exchange-traded funds, dismissing them as investments for “losers” even as Bitcoin ETFs recorded $552 million in inflows this week.  At the same time, the Rich Dad Poor Dad author threw his support behind President Donald Trump’s new executive order, which opens U.S. retirement accounts to crypto and …

Robert Kiyosaki Says Bitcoin ETFs for “Losers,” Applauds Trump’s Crypto Order

2025/09/17 17:41
3 min read
Robert Kiyosaki Says Bitcoin ETFs for “Losers,” Applauds Trump’s Crypto Order

The post Robert Kiyosaki Says Bitcoin ETFs for “Losers,” Applauds Trump’s Crypto Order appeared first on Coinpedia Fintech News

Robert Kiyosaki has brought back his fight against exchange-traded funds, dismissing them as investments for “losers” even as Bitcoin ETFs recorded $552 million in inflows this week. 

At the same time, the Rich Dad Poor Dad author threw his support behind President Donald Trump’s new executive order, which opens U.S. retirement accounts to crypto and other alternative assets.

Why the hostile take? Here are the details.

“ETFs Are for Losers”

In a post on X, Kiyosaki didn’t hold back:

He argued that ETFs are a poor substitute for direct ownership of assets like Bitcoin. According to him, only investors willing to “study” and do their “homework” should consider crypto or alternative investments, while casual investors should stick with traditional mutual funds.

His criticism comes at a time when spot Bitcoin ETFs are seeing strong demand. With over half a billion dollars in inflows this week and only two days of outflows this month, institutional buying remains clear. 

Still, Kiyosaki has repeated his stance that he would “never” buy a Bitcoin ETF.

Trump’s New Order Gets Applause

Kiyosaki balanced his criticism with praise for Donald Trump. He welcomed the August 7 executive order that allows 401(k) investors to diversify into real estate, private equity, precious metals, and cryptocurrencies.

For Kiyosaki, the order marks a turning point as it gives experienced investors more control over their portfolios while keeping tax benefits intact.

ETFs vs. Direct Ownership

Kiyosaki’s latest comments brought back an old debate in crypto. On one side are purists who believe real value comes from holding Bitcoin directly, without relying on Wall Street products. On the other side are investors who see ETFs as a practical way to get exposure without the complications of wallets and private keys.

Not everyone agreed with Kiyosaki’s harsh words. One user responded: “Those who simply want their wealth to grow are consciously choosing to delegate the monitoring and management to mutual funds. While direct stock picking can be rewarding, it isn’t mandatory for everyone.”

That reaction captures why ETFs continue to attract billions.

Why do crypto ETFs remain popular?

  • Diversification: Gain exposure to a mix of assets instead of betting on just one.
  • Easy access: Tradeable through regular brokerage accounts, no crypto wallets required.
  • Added security: Regulated funds reduce risks like hacks or lost keys.
  • Professional management: Experts handle the day-to-day volatility.

Bitcoin Climbs Ahead of Fed Decision

Bitcoin currently trades at $116,786, gaining 0.93% in the last 24 hours. Traders are now waiting for the Federal Reserve’s interest rate call, with markets betting on a 96% chance of a 25-basis-point cut.Lower rates often boost risk assets like Bitcoin by reducing the appeal of bonds. History is also on Bitcoin’s side: data shows the fourth quarter has delivered an average return of 85% since 2013. Analysts like Tom Lee expect a “monster move” if the Fed eases policy.

Never Miss a Beat in the Crypto World!

Stay ahead with breaking news, expert analysis, and real-time updates on the latest trends in Bitcoin, altcoins, DeFi, NFTs, and more.

bell icon Subscribe to News
Market Opportunity
Union Logo
Union Price(U)
$0.001534
$0.001534$0.001534
+3.50%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26